Dyne Therapeutics Inc (DYN)

14.33 -0.04  -0.28% NASDAQ Oct 22, 16:00 14.26 -0.07  -0.49% After-Hours: 20:00 USD

Dyne Therapeutics Net Income (TTM):

-97.49M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Net Income (TTM) Chart

Export Data
Save Image
Print Image

Historical Net Income (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -97.49M
March 31, 2021 -76.52M
Dec. 31, 2020 -59.44M
Sept. 30, 2020 -36.19M
June 30, 2020 -28.14M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (TTM) Benchmarks

Veracyte Inc -63.07M
Moderna Inc 3.495B
BridgeBio Pharma Inc -495.27M

Net Income (TTM) Range, Past 5 Years

Minimum -97.49M Jun 2021
Maximum -28.14M Jun 2020
Average -59.56M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.